# CLIGAVYX
> **NDA210063** · New Drug Application · Sponsor: AVYXA HOLDINGS · Approved 2019-08-19
## Drug
- **FDA Application Number:** NDA210063
- **Application type:** New Drug Application
- **Brand name:** CLIGAVYX
- **Generic name:** Fulvestrant
- **Active ingredients:** FULVESTRANT
- **Dosage form:** SOLUTION
- **Route:** INTRAMUSCULAR
- **Marketing status:** Discontinued
- **Sponsor:** AVYXA HOLDINGS
- **First approval:** 2019-08-19
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210063)
---
*AI Analytics · CC0 1.0*